Cyproterone acetate, ethinyl estradiol drug combination
Showing 51 - 75 of >10,000
Diabetes, Type 2 Trial in Berlin (Semaglutide 1.34 mg/mL, Semaglutide 3.0 mg/mL, NNC0480-0389 10 mg/mL)
Recruiting
- Diabetes Mellitus, Type 2
- Semaglutide 1.34 mg/mL
- +4 more
-
Berlin, GermanyNovo Nordisk Investigational Site
Jan 3, 2022
Abnormal Uterine Bleeding, Tranexamic Acid, Estrogen Trial in Bangkok, Phaya Thai (Tranexamic acid 250 mg oral tablet, Progynova
Not yet recruiting
- Abnormal Uterine Bleeding
- +3 more
- Tranexamic acid 250 mg oral tablet
- Progynova 1 mg oral tablet
-
Bangkok, Ratchathewi, Thailand
- +1 more
Sep 27, 2023
Oral Hormonal Contraceptive Use, Neural Activity, Mood Trial in Aurora (Levonorgestrel/ethinyl estradiol, Placebo)
Recruiting
- Oral Hormonal Contraceptive Use
- +3 more
- Levonorgestrel/ethinyl estradiol
- Placebo
-
Aurora, ColoradoUniversity of Colorado Denver Anschutz Medical Campus
Jan 25, 2022
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Metastatic
Not yet recruiting
- FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
- +4 more
- Computed Tomography
- +3 more
- (no location specified)
Sep 13, 2022
Osteoporosis Risk, Menopause Trial in Amsterdam (Estradiol patch, Progesterone)
Not yet recruiting
- Osteoporosis Risk
- Menopause
- Estradiol patch
- Progesterone
-
Amsterdam, NetherlandsAmsterdam UMC
Jun 12, 2023
Native Estrogen Estetrol (E4) Safety Study
Recruiting
- Contraception
- Birth Control
-
Berlin, GermanyBerlin Center for Epidemiology and Health Research
Aug 31, 2023
Prostate Hyperplasia Trial in Banha (cyproterone acetate, finasteride, no treatment received)
Completed
- Prostate Hyperplasia
- cyproterone acetate
- +2 more
-
Banhā, Qalyubia, EgyptBenha University
Jul 20, 2021
Breast Cancer Trial in Worldwide (Docetaxel / Capecitabine, Capecitabine / Vinorelbine, Paclitaxel / Gemcitabine)
Active, not recruiting
- Breast Cancer
- Docetaxel / Capecitabine
- +5 more
-
Cairo, Egypt
- +51 more
Oct 24, 2022
Other Disorders of Bone Development and Growth Trial in University Park (Combined Oral Contraceptive (COC), Contraceptive
Active, not recruiting
- Other Disorders of Bone Development and Growth
- Combined Oral Contraceptive (COC)
- Contraceptive Vaginal Ring (CVR)
-
University Park, PennsylvaniaWomen's Health and Exercise Laboratories, The Pennsylvania State
Mar 31, 2022
Healthy Trial in Mannheim (Microgynon®, BI 425809)
Recruiting
- Healthy
- Microgynon®
- BI 425809
-
Mannheim, GermanyCRS Clinical Research Services Mannheim GmbH
Jan 30, 2023
Endometriosis Trial in Worldwide (Relugolix, Estradiol/norethindrone acetate)
Active, not recruiting
- Endometriosis
- Relugolix
- Estradiol/norethindrone acetate
-
Andalusia, Alabama
- +168 more
May 31, 2022
Prostate Cancer Trial (Neoadjuvant treatment)
Not yet recruiting
- Prostate Cancer
- Neoadjuvant treatment
- (no location specified)
Oct 19, 2022
Contraception Trial in United States (Relugolix Combination Therapy)
Recruiting
- Contraception
- Relugolix Combination Therapy
-
Birmingham, Alabama
- +111 more
Jan 12, 2023
Uterine Fibroids, Heavy Menstrual Bleeding Trial in China (BG2109, Placebo for BG2109, Placebo for add-back therapy)
Recruiting
- Uterine Fibroids
- Heavy Menstrual Bleeding
- BG2109
- +3 more
-
Beijing, China
- +30 more
Nov 10, 2022
Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for
Active, not recruiting
- Heavy Menstrual Bleeding
- Fibroid Uterus
- Groups 1 and 2 myomectomy and uterine artery embolization, respectively, are surgical/procedure
- Elagolix Oral Product
-
Washington, District of ColumbiaMedStar Washington Hospital Center
Apr 29, 2022
Prostate Cancer Trial in Cleveland (Leuprolide acetate, Apalutamide, Radical prostatectomy)
Completed
- Prostate Cancer
- Leuprolide acetate
- +2 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
May 25, 2022
Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)
Active, not recruiting
- Prostate Cancer
- Prostatic Neoplasm
- abiraterone acetate in combination with prednisone
-
Homewood, Alabama
- +44 more
Jan 17, 2023
Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)
Recruiting
- Metastatic Hormone Refractory Prostate Cancer
- Cabozantinib
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 6, 2022
Obesity Trial in Berlin (Cagrilintide, Cagrilintide Placebo, Moxifloxacin)
Not yet recruiting
- Obesity
- Cagrilintide
- +3 more
-
Berlin, GermanyNovo Nordisk Investigational Site
Mar 27, 2023
Transgenderism, Clotting Disorder Trial in Milwaukee (Estradiol Tablets, Transdermal patch)
Terminated
- Transgenderism
- Clotting Disorder
- Estradiol Tablets
- Transdermal patch
-
Milwaukee, WisconsinFroedtert Hospital
Dec 19, 2022
HIV-1-infection Trial in Reutov (Elpida®, Rifampin, Rifabutin)
Completed
- HIV-1-infection
- Elpida®
- +6 more
-
Reutov, Moscow Region, Russian FederationCentral Clinical City Hospital
Jan 10, 2022